‌

US Patent 10730821 Site-specific isotopic labeling of 1,4-diene systems

Patent 10730821 was granted and assigned to Retrotope Inc. on August, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Retrotope Inc.

Current Assignee

Retrotope Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

107308210

Date of Patent

August 4, 2020

Patent Application Number

157781820

Date Filed

September 9, 2016

Patent Citations Received

‌

US Patent 12109194 Synergistic combination therapy for treating ALS

‌

US Patent 11510889 Methods for inhibiting the progression of neurodegenerative diseases

‌

US Patent 11447441 Site-specific isotopic labeling of 1,4-diene systems

‌

US Patent 12060324 Site-specific isotopic labeling of 1,4-diene systems

‌

US Patent 11491130 Methods of treating amyotrophic lateral sclerosis

‌

US Patent 11779910 Processes for isotopic modification of polyunsaturated fatty acids and derivatives thereof

Patent Primary Examiner

‌

Paul A. Zucker

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10730821 Site-specific isotopic labeling of 1,4-diene systems

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API